Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor.
Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ.
Biochemistry. 1990 Mar 6;29(9):2335-42.
Similar articles
Identification and function of disulfide bridges in the extracellular domains of the angiotensin II type 2 receptor.
Heerding JN, Hines J, Fluharty SJ, Yee DK.
Biochemistry. 2001 Jul 27;40(28):8369-77.
The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines.
Noda K, Saad Y, Graham RM, Karnik SS.
J Biol Chem. 1994 Mar 4;269(9):6743-52.
Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation.
Fraser CM.
J Biol Chem. 1989 Jun 5;264(16):9266-70.
Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.
D'Angelo DD, Eubank JJ, Davis MG, Dorn GW 2nd.
J Biol Chem. 1996 Mar 15;271(11):6233-40.
Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
Wo ZG, Oswald RE.
Mol Pharmacol. 1996 Oct;50(4):770-80.
Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA, Doufexis M, Kapas S, Chhajlani V.
Biochem Biophys Res Commun. 2001 Mar 9;281(4):851-7.
A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation.
Knudsen SM, Tams JW, Wulff BS, Fahrenkrug J.
FEBS Lett. 1997 Jul 21;412(1):141-3.
Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
Qi LJ, Leung AT, Xiong Y, Marx KA, Abou-Samra AB.
Biochemistry. 1997 Oct 14;36(41):12442-8.
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.
Blanpain C, Lee B, Vakili J, Doranz BJ, Govaerts C, Migeotte I, Sharron M, Dupriez V, Vassart G, Doms RW, Parmentier M.
J Biol Chem. 1999 Jul 2;274(27):18902-8.
Structural features required for ligand binding to the beta-adrenergic receptor.
Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD.
EMBO J. 1987 Nov;6(11):3269-75.
Mutating the four extracellular cysteines in the chemokine receptor CCR6 reveals their differing roles in receptor trafficking, ligand binding, and signaling.
Ai LS, Liao F.
Biochemistry. 2002 Jul 2;41(26):8332-41.
An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation.
Cook JV, Eidne KA.
Endocrinology. 1997 Jul;138(7):2800-6.
Fat cell beta 1-adrenergic receptor: structural evidence for existence of disulfide bridges essential for ligand binding.
Moxham CP, Malbon CC.
Biochemistry. 1985 Oct 22;24(22):6072-7.
Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.
Ehrlich GK, Andria ML, Zheng X, Kieffer B, Gioannini TL, Hiller JM, Rosenkranz JE, Veksler BM, Zukin RS, Simon EJ.
Can J Physiol Pharmacol. 1998 Mar;76(3):269-77.
Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents.
Gaibelet G, Capeyrou R, Dietrich G, Emorine LJ.
FEBS Lett. 1997 May 19;408(2):135-40.
Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Zhang P, Johnson PS, Zöllner C, Wang W, Wang Z, Montes AE, Seidleck BK, Blaschak CJ, Surratt CK.
Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204.
Reversible inactivation of AT(2) angiotensin II receptor from cysteine-disulfide bond exchange.
Feng YH, Saad Y, Karnik SS.
FEBS Lett. 2000 Nov 3;484(2):133-8.
Role of the Cys90, Cys95 and Cys173 residues in the structure and function of the human platelet-activating factor receptor.
Le Gouill C, Parent JL, Rola-Pleszczynski M, Stanková J.
FEBS Lett. 1997 Feb 3;402(2-3):203-8.
The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.
Schülein R, Zühlke K, Oksche A, Hermosilla R, Furkert J, Rosenthal W.
FEBS Lett. 2000 Jan 21;466(1):101-6. Erratum in: FEBS Lett 2000 May 4;473(1):124.
Filters: Manage Filters